Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Obesity-associated epigenetic alterations and the obesity-breast cancer axis.
Lagarde CB, Kavalakatt J, Benz MC, Hawes ML, Arbogast CA, Cullen NM, McConnell EC, Rinderle C, Hebert KL, Khosla M, Belgodere JA, Hoang VT, Collins-Burow BM, Bunnell BA, Burow ME, Alahari SK. Lagarde CB, et al. Among authors: alahari sk. Oncogene. 2024 Mar;43(11):763-775. doi: 10.1038/s41388-024-02954-0. Epub 2024 Feb 3. Oncogene. 2024. PMID: 38310162 Review.
The Non-Coding RNA Journal Club: Highlights on Recent Papers-13.
Shiu PKT, DiStefano JK, Alahari SK, Enguita FJ, Feinberg MW, Sideris N, Bayraktar S, Castellano L, Buitrago DL, Caporali A, Mannucci A, Goel A. Shiu PKT, et al. Among authors: alahari sk. Noncoding RNA. 2023 Dec 14;9(6):76. doi: 10.3390/ncrna9060076. Noncoding RNA. 2023. PMID: 38133210 Free PMC article.
17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer.
Drula R, Pardini B, Fu X, De Los Santos MC, Jurj A, Pang L, El-Daly SM, Fabris L, Knutsen E, Dragomir MP, Bayraktar R, Li Y, Chen M, Del Vecchio F, Berland L, Dae J, Fan D, Shimizu M, Tran AM, Barzi M, Pioppini C, Gutierrez AM, Ivan C, Meas S, Hall CS, Alahari SK, Berindan-Neagoe I, Fabbri M, Lucci A, Arun B, Anfossi S, Calin GA. Drula R, et al. Among authors: alahari sk. Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2122053120. doi: 10.1073/pnas.2122053120. Epub 2023 May 30. Proc Natl Acad Sci U S A. 2023. PMID: 37252969 Free PMC article.
The Non-Coding RNA Journal Club: Highlights on Recent Papers-12.
Shiu PKT, Ilieva M, Holm A, Uchida S, DiStefano JK, Bronisz A, Yang L, Asahi Y, Goel A, Yang L, Nuthanakanti A, Serganov A, Alahari SK, Lin C, Pardini B, Naccarati A, Jin J, Armanios B, Zhong XB, Sideris N, Bayraktar S, Castellano L, Gerber AP, Lin H, Conn SJ, Sleem DMM, Timmons L. Shiu PKT, et al. Among authors: alahari sk. Noncoding RNA. 2023 Apr 18;9(2):28. doi: 10.3390/ncrna9020028. Noncoding RNA. 2023. PMID: 37104010 Free PMC article.
LKB1 signaling and patient survival outcomes in hepatocellular carcinoma.
Nguyen K, Hebert K, McConnell E, Cullen N, Cheng T, Awoyode S, Martin E, Chen W, Wu T, Alahari SK, Izadpanah R, Collins-Burow BM, Lee SB, Drewry DH, Burow ME. Nguyen K, et al. Among authors: alahari sk. Pharmacol Res. 2023 Jun;192:106757. doi: 10.1016/j.phrs.2023.106757. Epub 2023 Apr 5. Pharmacol Res. 2023. PMID: 37023992 Free article. Review.
Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.
Yousefi H, Khosla M, Lauterboeck L, Okpechi SC, Worthylake D, Garai J, Zabaleta J, Guidry J, Zarandi MA, Wyczechowska D, Jayawickramarajah J, Yang Q, Kissil J, Alahari SK. Yousefi H, et al. Among authors: alahari sk. Oncogene. 2023 Mar;42(11):859. doi: 10.1038/s41388-023-02608-7. Oncogene. 2023. PMID: 36759576 No abstract available.
A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming.
Yousefi H, Khosla M, Lauterboeck L, Okpechi SC, Worthylake D, Garai J, Zabaleta J, Guidry J, Zarandi MA, Wyczechowska D, Jayawickramarajah J, Yang Q, Kissil J, Alahari SK. Yousefi H, et al. Among authors: alahari sk. Oncogene. 2022 Nov;41(47):5076-5091. doi: 10.1038/s41388-022-02497-2. Epub 2022 Oct 15. Oncogene. 2022. PMID: 36243802
Ceritinib is a novel triple negative breast cancer therapeutic agent.
Dong S, Yousefi H, Savage IV, Okpechi SC, Wright MK, Matossian MD, Collins-Burow BM, Burow ME, Alahari SK. Dong S, et al. Among authors: alahari sk. Mol Cancer. 2022 Jun 29;21(1):138. doi: 10.1186/s12943-022-01601-0. Mol Cancer. 2022. PMID: 35768871 Free PMC article.
Expression of Novel Kinase MAP3K19 in Various Cancers and Survival Correlations.
Nguyen K, Yousefi H, Cheng T, Magrath J, Hartono AB, Alzoubi M, Hebert K, Brock CK, Wright MK, Byrne CE, Rivera A, Okpechi SC, Matossian MD, Wathieu H, Elliott S, Mondrinos MJ, Lee SB, Collins-Burow BM, Alahari SK, Drewry DH, Burow ME. Nguyen K, et al. Among authors: alahari sk. Front Biosci (Landmark Ed). 2022 Jun 17;27(6):196. doi: 10.31083/j.fbl2706196. Front Biosci (Landmark Ed). 2022. PMID: 35748272 Free article. Review.
72 results